Making informed decisions Ozempic, Wegovy, and Mounjaro are similar drugs, but theyre not identical
It is not a character flaw
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
PeterMD is worth a look if you want deeper long-term hormone optimization, but for straightforward ED medication pricing, PeterMD is overpriced
MEDICAL DISCLAIMER : Educational content only
Many different mechanisms account for these powerful effects on the heart and blood vessels
